Sites
Tags
- A
- Abbott Laboratories
- Acebutolol
- Acepromazine
- Acetophenazine
- Adjuvant therapy
- Adrenergic receptor
- Agomelatine
- Alcohol
- Alpha-1A adrenergic receptor
- Alpha-2 adrenergic receptor
- Amantadine
- Amenorrhoea
- American Society of Health-System Pharmacists
- Amisulpride
- Amitraz
- Amitriptyline
- Amnesia
- Amoxapine
- Amphetamine
- Angioedema
- Anticholinergic
- Antidepressant
- Antihistamine
- Antipsychotic
- Antipsychotics
- Anxiety
- Anxiety disorder
- Aplastic anemia
- Apomorphine
- Aripiprazole
- Aripiprazole lauroxil
- Asenapine
- Atenolol
- Atypical antipsychotic
- Australia
- Autism
- Autism spectrum
- Azaperone
- Benperidol
- Beta-1 adrenergic receptor
- Beta blocker
- Bioavailability
- Biological half-life
- Bipolar disorder
- Bisoprolol
- Blood sugar
- Boxed warning
- Brexpiprazole
- Brimonidine
- British National Formulary
- Bromoacetylalprenololmenthane
- Bromocriptine
- Bromperidol
- Bryan Roth
- Bufotenin
- Bupropion
- Buspirone
- Butaperazine
- Butyrophenone
- Cannabidiol
- Cardiac Arrest
- Cardiovascular disease
- Carfenazine
- Cariprazine
- Carteolol
- Carvedilol
- CAS Registry Number
- ChEBI
- Chemical formula
- Chlorpromazine
- Chlorprothixene
- Cholesterol
- Cisapride
- Clenbuterol
- Clinical trial
- Clomipramine
- Clonidine
- Clopenthixol
- Clotiapine
- Clozapine
- Committee for Medicinal Products for Human Use
- Corynanthine
- Creatine kinase
- Creatinine
- Cyamemazine
- CYP1A2
- CYP2D6
- CYP3A4
- Dementia
- Department of Health
- Dexfenfluramine
- Dexmedetomidine
- Diabetes
- Dipivefrine
- Disabilities
- Dixyrazine
- DOI
- Domperidone
- Dopamine
- Dopamine receptor
- Dopamine receptor D2
- Dopamine receptor D3
- Dopamine receptor D4
- Dopaminergic pathways
- Dorsolateral prefrontal cortex
- Downregulation and upregulation
- Dox
- Doxazosin
- Doxepin
- Droperidol
- Droxidopa
- Drug class
- Drug metabolism
- Drug nomenclature
- DSM-5
- Dysphagia
- Efavirenz
- Eletriptan
- Enzyme inhibitor
- Eosinophilia
- Epinephrine
- Ergoline
- Ergotamine
- Erythema multiforme
- Esketamine
- European Chemicals Agency
- European Medicines Agency
- Example
- Excretion
- Exocytosis
- Extrapyramidal symptoms
- Feces
- Fenfluramine
- Fluoxetine
- Flupentixol
- Fluphenazine
- Fluspirilene
- Food and Drug Administration
- Formoterol
- Fractionated coconut oil
- Frovatriptan
- Galactorrhea
- Glaucoma
- Glucagon-like peptide-1 receptor agonist
- Guanfacine
- Gynecomastia
- Haloperidol
- Halothane
- HDL
- Histamine H1 receptor
- Hydroxyzine
- Hyperglycemia
- Hyperprolactinaemia
- Hypersensitivity
- Hypotension
- Iloperidone
- Imipramine
- Influenza-like illness
- Inhalational anaesthetic
- Insulin resistance
- International Chemical Identifier
- International Standard Book Number
- International Standard Serial Number
- Intramuscular injection
- Isoflurane
- KEGG
- Ketamine
- Kidney
- Labetalol
- Latrepirdine
- L-DOPA
- Leukopenia
- Levofenfluramine
- Levomepromazine
- Levosalbutamol
- Levosulpiride
- Lithium
- Liver
- Long QT syndrome
- Lorcaserin
- Loxapine
- Lundbeck
- Lurasidone
- Lysergic Acid Diethylamide
- Lysine
- Major depressive disorder
- Mania
- Maprotiline
- MDMA
- Medetomidine
- Medicines and Healthcare products Regulatory Agency
- Medium-chain triglyceride
- Melperone
- Memantine
- Mescaline
- Mesoridazine
- Metabolic syndrome
- Metabolism
- Meta-Chlorophenylpiperazine
- Metformin
- Metoclopramide
- Metoprolol
- Mianserin
- Microcrystalline
- Microsphere
- Midodrine
- Mirabegron
- Mirtazapine
- Mixed affective state
- MMDA
- Modafinil
- Molar mass
- Molindone
- Moperone
- Motor control
- MPPF
- Muscarinic acetylcholine receptor M1
- Myocarditis
- Nadolol
- Nanocrystalline material
- Naphazoline
- National Health Service
- National Institute of Mental Health
- N-Butanol
- Nefazodone
- Neuroleptic
- Neuroleptic malignant syndrome
- Neutropenia
- Nitrous oxide
- Nizatidine
- N,N-Dimethyltryptamine
- Norepinephrine
- Norfenfluramine
- Nortriptyline
- Nuciferine
- Obesity
- Obsessive–compulsive disorder
- OCLC
- Off-label use
- Olanzapine
- Ondansetron
- Oral administration
- Orthostatic hypotension
- Oxymetazoline
- Oxypertine
- Paliperidone
- Pancreatitis
- Parkinson's disease
- Penfluridol
- Perazine
- Periciazine
- Perphenazine
- Persecutory delusion
- Pharmaceuticals and Medical Devices Agency
- Pharmacodynamics
- Pharmacokinetics
- Phases of clinical research
- Phencyclidine
- Phenothiazine
- Phentolamine
- Phenylalanine
- Phenylephrine
- Phenylpropanolamine
- Physicians' Desk Reference
- Pimozide
- Pindolol
- Pipamperone
- Piperacetazine
- Piperazine
- Pipotiazine
- Plasma protein binding
- PMC
- Potency
- Practolol
- Pramipexole
- Prazosin
- Priapism
- Prochlorperazine
- Producer
- Prolactin
- Promazine
- Promethazine
- Propranolol
- Prothipendyl
- Prucalopride
- Psilocin
- Psilocybin
- Psychomotor agitation
- Psychosis
- PubChem
- PubMed
- QT interval
- Quetiapine
- Quinidine
- Ractopamine
- Receptor
- Receptor modulator
- Regulation of therapeutic goods
- Remoxipride
- Respiratory arrest
- Rhabdomyolysis
- Rigidity
- Rilmenidine
- Risperidone
- Route of administration
- Salbutamol
- Salmeterol
- Schizophrenia
- Seizures
- Serotonin
- Serotonin antagonist and reuptake inhibitor
- Sertindole
- Sesame oil
- Sevoflurane
- Sexual dysfunction
- Skeletal formula
- Sotalol
- Standard for the Uniform Scheduling of Medicines and Poisons
- Status epilepticus
- Stevens–Johnson syndrome
- Stroke
- Substituted amphetamine
- Substituted phenethylamine
- Substituted tryptamine
- Suicidal ideation
- Suicide
- Sulpiride
- Sultopride
- Sumatriptan
- Suspension
- Syncope
- Synephrine
- Synonym
- Tachykinin receptor
- Tamsulosin
- Tardive dyskinesia
- Terazosin
- Terbutaline
- Tetrabenazine
- Tetracyclic antidepressant
- Tetryzoline
- The Lancet
- Therapeutic Goods Administration
- Therapy
- Thiopropazate
- Thioproperazine
- Thioridazine
- Thiothixene
- Thrombocytopenia
- Thrombotic thrombocytopenic purpura
- Thrombus
- Thujone
- Tiapride
- Tizanidine
- Toluene
- Topiramate
- Torsades de pointes
- Tramadol
- Tranquilizer
- Trazodone
- Tremor
- Tricyclic
- Tricyclic antidepressant
- Trifluoperazine
- Trifluperidol
- Triflupromazine
- Triglyceride
- Trimethobenzamide
- Trimipramine
- Triptan
- Tryptamine
- Typical antipsychotic
- Tyrosine
- United Kingdom
- United States National Library of Medicine
- University of Manchester
- Valerenic acid
- Valproate
- Vegetable oil
- Ventromedial prefrontal cortex
- Vilanterol
- Vilazodone
- Viscosity
- Vortioxetine
- Water
- Wayback Machine
- WebMD
- WHO Model List of Essential Medicines
- Xenon
- Xylazine
- Yohimbine
- Zilpaterol
- Ziprasidone
- Zolmitriptan
- Zotepine
- Zuclopenthixol